Deep Track Capital Maintains 2M Share Stake in Dyne Therapeutics
Ticker: DYN · Form: SC 13G/A · Filed: Jan 19, 2024 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | SC 13G/A |
| Filed Date | Jan 19, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, biotech
TL;DR
**Deep Track Capital still holds 2 million shares of Dyne Therapeutics, showing continued institutional confidence.**
AI Summary
Deep Track Capital, LP, a Delaware-based investment firm, filed an amended SC 13G/A on January 19, 2024, disclosing its beneficial ownership in Dyne Therapeutics, Inc. As of December 31, 2023, Deep Track Capital holds shared voting and dispositive power over 2,000,000 shares of Dyne Therapeutics' common stock. This filing indicates a significant institutional stake, which can be a positive signal for investors as it suggests a professional firm sees value in the company.
Why It Matters
This filing shows a major institutional investor, Deep Track Capital, continues to hold a substantial position in Dyne Therapeutics, signaling their ongoing confidence in the company's prospects. For investors, this can be a reassuring sign of institutional backing.
Risk Assessment
Risk Level: low — This filing indicates a stable institutional holding, which generally reduces perceived risk for other investors.
Analyst Insight
Investors should note the continued institutional interest from Deep Track Capital, LP, as their stable 2,000,000 share holding in Dyne Therapeutics, Inc. could be interpreted as a vote of confidence. This information might be used to validate existing investment theses or as a data point for further due diligence.
Key Numbers
- 2,000,000 — Shares Beneficially Owned (Represents the number of Dyne Therapeutics shares Deep Track Capital, LP has shared voting and dispositive power over as of December 31, 2023.)
- December 31, 2023 — Date of Event (This is the date for which the beneficial ownership information is reported, providing a clear snapshot of the holding.)
- January 19, 2024 — Filing Date (This is the date the SC 13G/A amendment was filed, indicating the recency of the disclosure.)
Key Players & Entities
- Deep Track Capital, LP (company) — the reporting person and investment firm
- Dyne Therapeutics, Inc. (company) — the subject company whose shares are being reported
- Delaware (company) — place of organization for Deep Track Capital, LP
- 2,000,000 (dollar_amount) — number of shares beneficially owned with shared voting and dispositive power
Forward-Looking Statements
- Deep Track Capital will maintain its significant stake in Dyne Therapeutics, Inc. through the next quarter. (Deep Track Capital, LP) — medium confidence, target: March 31, 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 2) to a Schedule 13G, filed by Deep Track Capital, LP, to report their beneficial ownership of Common Stock in Dyne Therapeutics, Inc. as of December 31, 2023, under Rule 13d-1(c) of the Securities Exchange Act of 1934.
Who is the reporting person in this filing and what is their organizational structure?
The reporting person is Deep Track Capital, LP, organized in Delaware. They are an investment firm that has filed this amendment to disclose their holdings in Dyne Therapeutics, Inc.
How many shares of Dyne Therapeutics, Inc. does Deep Track Capital, LP beneficially own, and what powers do they have over these shares?
As of December 31, 2023, Deep Track Capital, LP beneficially owns 2,000,000 shares of Dyne Therapeutics, Inc. They hold shared voting power over these 2,000,000 shares and shared dispositive power over the same 2,000,000 shares, with no sole voting or dispositive power.
What is the CUSIP number and par value of the securities reported in this filing?
The CUSIP number for Dyne Therapeutics, Inc. Common Stock is 26818M108, and the par value per share is $0.0001.
When was the 'Date of Event Which Requires Filing of this Statement' for this particular amendment?
The 'Date of Event Which Requires Filing of this Statement' for this amendment is December 31, 2023, indicating the snapshot date for the reported beneficial ownership.
Filing Stats: 1,391 words · 6 min read · ~5 pages · Grade level 10 · Accepted 2024-01-19 09:08:39
Key Financial Figures
- $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o
Filing Documents
- deeptrack-dyn123122a2.htm (SC 13G/A) — 99KB
- 0001172661-24-000277.txt ( ) — 101KB
(a)Name of Issuer
Item 1. (a)Name of Issuer Dyne Therapeutics, Inc.
(b)Address of Issuer’s Principal
Item 1. (b)Address of Issuer’s Principal Executive Offices 1560 Trapelo Road Waltham, MA 02451
(a)Names of Persons Filing
Item 2. (a)Names of Persons Filing: (i) Deep Track Capital, LP (ii) Deep Track Biotechnology Master Fund, Ltd. (iii) David Kroin
( b)Address
Item 2. ( b)Address of Principal Business Office: (i) 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830 (ii) c/o Walkers Corporate Limited, 190 Elgin Ave, George Town, KY1-9001, Cayman Islands (iii) c/o Deep Track Capital, LP, 200 Greenwich Ave, 3rd Floor, Greenwich, CT 06830
(c) Citizenship
Item 2. (c) Citizenship: (i) Delaware (ii) Cayman Islands (iii) United States
(d)Title of Class of Securities
Item 2. (d)Title of Class of Securities Common Stock, $0.0001 par value per share (the “Common Stock”)
(e) CUSIP No
Item 2. (e) CUSIP No.: 26818M108 CUSIP No. 26818M108 SCHEDULE 13G/A Page 6 of 9 Pages
If
Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) o An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) A group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable CUSIP No. 26818M108 SCHEDULE 13G/A Page 7 of 9 Pages Item 4.Ownership Information with respect to the Reporting Persons' ownership of the Common Stock as of December 31, 2023, is incorporated by reference to items (5) - (9) and (11) of the cover page of the respective Reporting Person. The amount beneficially owned by each Reporting Person is determined based on 61,383,648 common shares oustanding. Item 5.Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial Item 6.Ownership of More